Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAP3K1 |
| Upstream (Parents) |
|---|
| (<<) ARHGEF2 → MAP3K1 |
| (<<) ATF2 → MAP3K1 |
| (<<) B3GNT2 → MAP3K1 |
| (<<) BLNK → MAP3K1 |
| (<<) CASKIN1 → MAP3K1 |
| (<<) CASP1 → MAP3K1 |
| (<<) CASP2 → MAP3K1 |
| (<<) CASP8 → MAP3K1 |
| (<<) CRKL → MAP3K1 |
| (<<) CRTC1 → MAP3K1 |
| (<<) CSGALNACT2 → MAP3K1 |
| (<<) GNA11 → MAP3K1 |
| (<<) GSK3B → MAP3K1 |
| (<<) HMGCS1 → MAP3K1 |
| (<<) ITCH → MAP3K1 |
| (<<) LCE3D → MAP3K1 |
| (<<) MYL5 → MAP3K1 |
| (<<) NDRG1 → MAP3K1 |
| (<<) PAK2 → MAP3K1 |
| (<<) PDE4C → MAP3K1 |
| (<<) PIK3CG → MAP3K1 |
| (<<) PLCD3 → MAP3K1 |
| (<<) SIGLEC15 → MAP3K1 |
| (<<) TP53 → MAP3K1 |
| (<<) UBE2L6 → MAP3K1 |
| (<<) VAV3 → MAP3K1 |
| (<<) VIM → MAP3K1 |
| (<<) YWHAH → MAP3K1 |
| (<<) YWHAZ → MAP3K1 |
| Downstream (Children) |
|---|
| MAP3K1 → ADAM10 (>>) |
| MAP3K1 → CPD (>>) |
| MAP3K1 → GPR109B (>>) |
| MAP3K1 → ITGA2 (>>) |
| MAP3K1 → RASD1 (>>) |
